EP Patent

EP3412300A1 — Therapeutic agents comprising elastin-like peptides

Assigned to Duke University · Expires 2018-12-12 · 7y expired

What this patent protects

The present invention provides therapeutic agents and compositions comprising elastin-like peptides(ELPs) and therapeutic protein is a GLP-1 receptor agonist, insulin, or Factor VII/VIIa, including functional analogs. The present invention further provides encoding polynucleotide…

USPTO Abstract

The present invention provides therapeutic agents and compositions comprising elastin-like peptides(ELPs) and therapeutic protein is a GLP-1 receptor agonist, insulin, or Factor VII/VIIa, including functional analogs. The present invention further provides encoding polynucleotides, as well as methods of making and using the therapeutic agents. The therapeutic agents have improvements in relation to their use as therapeutics, including, inter alia, one or more of half-life, clearance and/or persistence in the body, solubility, and bioavailability.

Drugs covered by this patent

Patent Metadata

Patent number
EP3412300A1
Jurisdiction
EP
Classification
—
Expires
2018-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Duke University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.